Risk Indicators of Sarcoidosis Evolution-Unified Protocol

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

March 30, 2026

Study Completion Date

March 30, 2026

Conditions
Sarcoidosis, Pulmonary
Trial Locations (2)

21201

RECRUITING

University of Maryland, Baltimore

75390

RECRUITING

UT Southwestern, Dallas

All Listed Sponsors
collaborator

Vanderbilt University Medical Center

OTHER

collaborator

University of Texas, Southwestern Medical Center at Dallas

OTHER

collaborator

Wayne State University

OTHER

lead

University of California, San Francisco

OTHER